SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Form
Filing Date
Jan 6, 2021
Document Date
Jan 4, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc
Filer
Swisher Daniel N JR